Related Experiment Video
Updated: Oct 7, 2026

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
Published on: August 9, 2024
The PANDORA project: results of the cost of illness analysis
E Degli Esposti1, P Berto, P Ruffo
1Health Directorate, Ravenna Local Health Unit, Via De' Gasperi, 8-48100 Ravenna, Italy. edegliesposti@iol.it
Aims:
To evaluate the cost of illness from hypertension for the Italian National Health System (NHS).
Methods And Results:
A prospective analysis was carried out on clinical and economic data recorded in the general practitioners' (GPs) database. Twenty-one GPs working in the Ravenna area in Italy took part in the project on a voluntary basis. The study included 1047 hypertensive patients enrolled between 1 June and 31 December 1997 and continued for 365 days from the date of enrolment. The following costs were calculated: antihypertensive drugs, laboratory tests and instrumental procedures, GP visits for blood pressure control, specialist visits, casualty visits, hospitalisation due to cardiovascular problems. In the whole sample, the most relevant cost is due to antihypertensive drugs (42.7%), followed by hospital admission (28.4%), GP visits (15.1%) and tests (10.6%). The total mean cost was significantly lower in incident (no previous treatment) than in prevalent patients (already treated) (457 512 vs 725 573 Italian Lira (ITL), P < 0.05) and in older rather than in younger patients (1171 410 vs 796 452 (ITL) P < 0.05). (In the text the equivalent is given in Euros, Pounds Sterling and US dollars).
Conclusion:
Our study should be considered as preliminary, nevertheless it could represent a step towards the evaluation of the true cost of hypertension.
Related Concept Videos
Factors Affecting Illness
For instance, risk factors are connected to illness, disability,...
Models of Health Promotion and Illness Prevention II
The agent-host-environment model states that disease results from...
Methods Of Healthcare Delivery System
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is limited...
Dimensions of Health and Illness
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Concepts of Health and Illness